Astellas Pharma Inc (ALPMF)
Market Closed
14 Oct, 08:00 PM
$
13. 00
-0.1
-0.7634%
$
26.05B Market Cap
152.62 P/E Ratio
78% Div Yield
2,700 Volume
0.14 Eps
$ 13.1
Previous Close Want to track ALPMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Astellas Pharma Inc (ALPMF) Statistics
Valuation metrics
Market Cap 26.05B
Enterprise value 4.37T
Trailing P/E (ttm) 11.03
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 1.77
Price/Book (mrq) 2.07
Enterprise Value/Revenue 1.92
Enterprise Value/EBITDA 6.46
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 6K
Average volume (90 days) 1.8K
Price summary
52-Week low 9.85
52-Week high 17.85
Beta -
50-Day moving average 15.2
200-Day moving average 14.8
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 79
Trailing annual dividend yield 0.0352%
5-Year annual dividend yield -
Payout ratio 0.38
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 5:1
Last split Date 27 Mar 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.16%
Operating margin 0.22%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1,269.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 203.6
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 136.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.3
Current ratio (mrq) 1.2%
Book value per share (mrq) 1,085.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
